COMPARATIVE PHARMACOKINETICS AND METABOLISM OF DOXORUBICIN AND EPIRUBICIN IN PATIENTS WITH METASTATIC BREAST-CANCER

被引：0
|
作者：
ROBERT, J [1 ]
VRIGNAUD, P [1 ]
NGUYENNGOC, T [1 ]
ILIADIS, A [1 ]
MAURIAC, L [1 ]
HURTELOUP, P [1 ]
机构：
[1] FAC PHARM MARSEILLE,F-13385 MARSEILLE 4,FRANCE
来源：
CANCER TREATMENT REPORTS | 1985年 / 69卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：633 / 640
页数：8
相关论文
共 50 条
  • [41] FAC (FLUOROURACIL, DOXORUBICIN, CYCLOPHOSPHAMIDE) AS 2ND LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER PROGRESSING UNDER FEC (FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE) CHEMOTHERAPY
    CATIMEL, G
    CHAUVIN, F
    GUASTALLA, JP
    REBATTU, P
    BIRON, P
    CLAVEL, M
    ANNALS OF ONCOLOGY, 1994, 5 (01) : 95 - 97
  • [42] EPIRUBICIN IN THE COMBINATION CHEMOTHERAPY OF METASTATIC BREAST-CANCER (VEC) AND THE ADVANCED OVARIAN-CANCER (PEC)
    CHRISTMANN, D
    ONKOLOGIE, 1986, 9 : 11 - 12
  • [43] WEEKLY 1ST-LINE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH CYCLOPHOSPHAMIDE AND EPIRUBICIN
    ALBA, E
    BLANCO, E
    ARANDA, E
    LASSO, R
    ALONSO, L
    BELON, J
    GARCIA, A
    SANCHEZCHAPARRO, MA
    BRETON, JJ
    TUMORI, 1992, 78 (05) : 338 - 340
  • [44] INTRAPATIENT COMPARISON OF SINGLE-AGENT EPIRUBICIN WITH OR WITHOUT LONIDAMINE IN METASTATIC BREAST-CANCER
    LOPEZ, M
    VICI, P
    DILAURO, L
    PAOLETTI, G
    GIONFRA, T
    CONTI, F
    CARPANO, S
    PIGNATTI, F
    GIANNARELLI, D
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) : 1611 - 1614
  • [45] POLYCHEMOTHERAPEUTIC TREATMENT OF PATIENTS WITH METASTATIC BREAST-CANCER
    BALAZS, M
    TUSKE, M
    ACTA MEDICA HUNGARICA, 1986, 43 (04) : 407 - 411
  • [46] VALUE OF ADRENALECTOMY IN PATIENTS WITH METASTATIC BREAST-CANCER
    DAO, TL
    SURGICAL CLINICS OF NORTH AMERICA, 1978, 58 (04) : 801 - 808
  • [47] HEPATOTOXICITY OF HYCANTHONE IN PATIENTS WITH METASTATIC BREAST-CANCER
    HAQ, MM
    LEGHA, SS
    WISEMAN, CW
    BODEY, GP
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 929 - 932
  • [48] THE PHARMACOKINETICS OF HIGH-DOSE EPIRUBICIN AND OF THE CARDIOPROTECTOR ADR-529 GIVEN TOGETHER WITH CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND TAMOXIFEN IN METASTATIC BREAST-CANCER PATIENTS
    JAKOBSEN, P
    SORENSEN, B
    BASTHOLT, L
    MIRZA, MR
    GJEDDE, SB
    MOURIDSEN, HT
    ROSE, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 35 (01) : 45 - 52
  • [49] Pharmacokinetics and pharmacodynamics of combination chemotherapy with paclitaxel and epirubicin in breast cancer patients
    Danesi, R
    Innocenti, F
    Fogli, S
    Gennari, A
    Baldini, E
    Di Paolo, A
    Salvadori, B
    Bocci, G
    Conte, PF
    Del Tacca, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (05) : 508 - 518
  • [50] PHARMACOKINETICS OF RADIOLABELED MONOCLONAL-ANTIBODY B6.2 IN PATIENTS WITH METASTATIC BREAST-CANCER
    HAYES, DF
    ZALUTSKY, MR
    KAPLAN, W
    NOSKA, M
    THOR, A
    COLCHER, D
    KUFE, DW
    CANCER RESEARCH, 1986, 46 (06) : 3157 - 3163
12345